Resistance (R) factor-mediated streptomycin (Sm) resistance differs from classical, high-level, chromosome-borne Sm resistance in its dominance over sensitivity and in the level of its effectiveness (in Escherichia coil -25 pg/ml versus >2,000 jg/ ml). In addition, an R factor-containing strain, unlike high-level Sm-resistant bacteria, showed an inoculum effect with respect to its level of Sm resistance. Crude extracts of this strain destroyed the inhibitory activity of Sm and bluensomycin (Blue) on in vitro protein synthesis. The ribosomes from this strain proved to be sensitive to Sm in vitro. The requirements for in vitro inactivation of Sm (and Blue) were determined to be: extract, adenosine triphosphate or deoxyadenosinetriphosphate, and Mg+. Chromatographic techniques with radioisotopes revealed the formation of an inactivated form of Sm containing adenosine (or deoxyadenosine), phosphate, and Sm in equimolar amounts. The adenylate moiety is coupled to the streptobiosamine residue, rather than to the streptidine ring, of the Sm molecule. The adenylating enzyme, which is not induced by Sm, is located in the periplasmic space of the R factor-containing strain.
Resistance (R) factors are extrachromosomal genetic elements, or episomes, that mediate resistance to various antibacterial drugs and were defined originally in species of Shigelia in Japan (26) . They have subsequently been found to have a world-wide distribution in all species of enteric bacteria and are now the most common basis for drug resistance among such organisms isolated in the United States (D. H. Smith, Proc. Intern. Symp. Infect. Multiple Drug Resistance, in press). The mechanism by which R factors confer drug resistance has, therefore, medical as well as biological importance.
Drug resistance associated with R factors was originally thought to result from decreased permeability to the drugs (12, 15) ; evidence has been presented recently, however, which suggests that these episomes bear genes for individual enzymes which inactivate chloramphenicol (10, 17, 18) , kanamycin (Kana; 10, 23), dihydrostreptomycin (10, 24) , neomycin (Neo) and paromomycin (22) , and ampicillin (1, 4) .
In this communication, we present evidence that cells bearing R factors contain an enzyme located in the periplasmic space which inactivates streptomycin by adenylation. Some of these results were reported previously (D. H. Smith, Intern. Symp. Infect. Multiple Drug Resistance, in press). While this work was in progress, UmeR FACTOR-MEDIATED STREPTOMYCIN RESISTANCE strain. For this assay, 0.1 ml of the solution to be assayed was placed into wells (5 mm in diameter) made in 30-ml tryptic digest agar (agar 1.5%) plates containing the indicator strain dispersed throughout the agar. The plates were incubated at room temperature overnight, then at 37 C for 12 hr. Growth inhibition was measured as the radius drawn between the outer edge of the well and the outermost edge of the zone of no growth.
Decrease of active Sm in culture medium. E. coli B/RE130 was grown overnight to stationary phase in tryptic digest broth containing 15 ;sg of Sm per ml.
The cells were pelleted by centrifugation, and the supernatant fluid was concentrated by heating at about 60 C under vacuum. The amount of biologically active Sm in this concentrated medium was evaluated by bioassay (see above). The following controls were used. (i) E. coli B was substituted for B/RE130; because strain B is sensitive to 1 MAg of Sm per ml, the initial concentration of Sm in the broth was 0.5 ,ug/ml. After growth of E. coli B to stationary phase, the culture supernatant fluid was concentrated under vacuum sufficiently so that its estimated final Sm concentration was equivalent to that of the concentrated B/RE130 supernatant fluid, assuming no inactivation of Sm by either strain. (ii) A volume of broth, uninoculated with any bacterium and containing 15 or 0.5 Mg of Sm per ml initially, was concentrated under vacuum to an estimated final Sm concentration which was comparable, as in the first control, to that of the experimental.
The osmotic shock procedure has already been described (8) .
In vitro protein synthesis. Cells were grown, washed, extracted, and fractionated into ribosomes and ISin0
[supernatant fluid from 100,000 X g centrifugation of crude cell extract which had been incubated at 37 C for 15 min with added amino acids and adenosine triphosphate (ATP) to exhaust endogenous messenger] supernatant fluid by methods previously described (5, 9). Incubations of polynucleotide-directed, cellfree protein synthetic reaction mixtures were prepared and assayed for radioactivity as described (6, 9) . Sm inactivation mixtures. Crude extracts employed as a source of Sm-adenylating enzyme were prepared as an IS,oo fraction and were dialyzed three times, 8 6 ;moles of ,B-mercaptoethanol, and 2 to 8 mg of protein extract of E. coli B or B/RE130 per ml of mixture.
These mixtures were incubated at 37 C for various intervals, at which time the reaction was stopped by heating at 80 to 95 C for 5 min. The resulting precipitate was removed by centrifugation twice at 3,000 X g for 15 min, and the supernatant fluid was collected for further study. [Heating at 100 C for 5 min had no untoward effect on either biological or colorimetric (16) assays for Sm. Furthermore, heat precipitation of the protein in the mixtures did not lead to nonspecific binding of Sm in the precipitate, since solutions of Sm at equal concentration in water or in a heated reaction mixture had identical biological activity.]
Chromatography. Thin-layer chromatography was performed on plates of PEI cellulose and diethylaminoethyl cellulose prepared according to Randerath (13) . After ascending chromatography to 15 to 16 cm in 0.1 M or 0.8 M LiCl, the plates were divided into 15 to 16 blocks, 1.0 cm long by 1.3 cm wide, which were taken up with a razor blade to scintillation vials. Radioactivity was counted in aqueous Bray's solution (2) 30 ,ug/ml, ATP at 10-' M, guanosine triphosphate at 5 X 10-' M, poly U at 100,ug/ml, streptomycin at 10 pg/ml, supernatant fluid at 7.5 mg of protein/ml, and ribosomes at 2.2 mg/ml. Streptomycin was incubated in the complete system minus ribosomes and mRNA for 60 min at 37 C; ribosomes and mRNA were then added as indicated, and reaction mixtures were incubated for 30 min at 37 C. Thereafter, samples were collected and counted as described (9 a Incubation conditions were similar to those described in Table 1 , with the following exceptions: magnesium acetate was used at 10-' M, ammonium acetate at 6 X 1Or-M, supernatant fraction of E. coli B at 3.5 mg of protein/ml, supernatant fraction of E. coli B/RE130 at 3.75 mg of protein/ml, and all antibiotics at 10 pg/ml. Ribosomes from E. coli B were used in all groups: for groups 1 to 4 the concentration was 3.9 mg/ml; for groups 5 to 10, 1.95 mg/ml. Antibiotics were added at the onset of incubation. Table 2 , except for the following: magnesium acetate was used at 2.7 X 10-' M, polyinosinic acid at 100 ug/ml, and IS3. fraction in amounts sufficient to yield 2.5 mg of ribosomes/ml. Spec was added at the beginning of a 30-min incubation period at 37 C. At the end of that period, specimens were collected and counted as before.
b Polyinosinic acid.
formed as in Table 5 a Incubation conditions were similar to those described in Table 1 with the following exceptions:
magnesium acetate was used at 3 X 10-' M, ammonium acetate at 8.6 X 10-' M, supernatant fraction of E. coli B at 3.5 mg of protein/ml, supernatant fraction of B/RE130 at 7.5 mg of protein/ml, E. coli B ribosomes at 2 mg of ribosomes/ml, and Blue at 10,ug/ml. Antibiotic was added at the outset of incubation. (Fig. 4) , described below, indicate participation of dATP in the inactivation of Sm. The results of parallel experiments established that the inactivation of Spec (and of Blue) also required ATP and Mg++ and raised the question of whether one or more than one enzyme is involved in the inactivation of Spec and Sm. Substrate competition experiments were therefore performed (Table 6 ) to help resolve this question.
These experiments demonstrated that increasing concentrations of Spec in the reaction mixture interfered with the enzymatic inactivation of a constant concentration of Sm. Conversely, Sm interfered with the inactivation of Spec. The degree of inhibition is not proportional, however, to the concentration of competing aminoglycoside substrate added.
Product of the Sm inactivation reaction. Radioactive substrates and thin-layer chromatography were employed to define the characteristics of the product of the Sm inactivation reaction. Samples of a reaction mixture containing "4C-Sm were chromatographed on PEI cellulose in neutral lithium salts after 0 and 4 hr of incubation, at which time no biologically active Sm was detectable in the mixture. The inactivated Sm had an Rp of 0.75 compared to 0.95 for Sm (Fig. 1) . Since this system of chromatography also separates nucleotides, nucleosides, and bases, it was employed in all of the following experiments.
The ATP requirement for inactivation permitted the use of ATP labeled variously to determine in what manner ATP was involved in the reaction. Figure 2 depicts the results of an experiment in which a,fB,y-32P-ATP was added to a reaction mixture. The chromatogram of a sample removed from the mixture before incubation indicated that ATP remains near the origin (peak 1). In the absence of Sm, the ATP was nonspecifically degraded by this crude extract to products (identified by comigration of various known adenine-containing compounds in parallel experiments) which had the Rp of peaks 1 and 2 (see also Fig. 4) . The chromatogram of a sample removed from an incubation in which the Sm was completely inactivated revealed a new 32P peak (peak 3) which had an Rr identical with inactivated Sm. The reaction mixture contained 2,070 nmoles of ATP and 345 nmoles of Sm. There were 64,000 32p counts/min on the chromatogram, and 3,160 were at an RP of 0.77 (counts/min at 12, 13, 14, and 15 cm from origin were pooled). These findings suggested that 1 mole of phosphate had been transferred from ATP to 1 mole of Sm in the course of the inactivation.
This did not, however, distinguish which of the three phosphates from ATP was involved in the inactivation. Therefore, the same experiment was repeated with a-32P-ATP, with or without 3H-Sm (Fig. 3) . The chromatogram of the complete reaction mixture with no incubation showed that ATP remained at the origin (peak 1), whereas Sm ran with the solvent front (peak 4). The 82P in a mixture containing no Sm and incubated for 4 hr was found in peaks 1 and 2 (ATP degradation products), whereas in a complete mixture incubated for 4 hr it was found in these two peaks and in a new peak (peak 3) coincident with the 3H-Sm. Samples were removed from the reaction mixture after 0 (top) and 4 hr (middle) of incubation and chromatographed as in Fig. 2 . A parallel reaction mixture containing a-as P-ATP and no Sm (bottom) was also sampled after a 4-hr incubation and was chromatographed similarly. those of the above experiments, indicate that Sm is inactivated by adenylation.
As noted earlier, dATP could replace the requirement for ATP in reaction mixtures. When chromatographically purified 3H-dATP replaced ATP in an incubation, 1 mole of dATP was found coupled to 1 mole of Sm in the product, providing further evidence for an active cofactor role for dATP in this reaction.
To define further the nature of the product, 3H-ATP was incubated with the streptidine and streptobiosamine degradation products of the Sm molecule (Fig. 5) . Streptobiosamine, but not streptidine, can be adenylated (peak 3) by the enzyme (Fig. 6) .
Lastly, mixtures of Spec and Blue in complete systems containing 3H-ATP were sampled after 0 and 4 hr of incubation and were chromatographed by the thin-layer technique. Comparison of the 'H distributions at 0 and 4 hr revealed the appearance at 4 hr of a new 3H peak, RF = 0.75 to 0.80, in the chromatograms of both Spec-and Bluecontaining reaction mixtures. In accord with the ATP dependence of both Spec and Blue inactivation, this finding further suggests that these two drugs are also inactivated by adenylation.
Location and regulation of the enzyme. Growth of E. coli B/RE130 to stationary phase in medium containing 15 ,ug of Sm per ml decreased the concentration of biologically active Sm in the medium (measured by bioassay) by more than 80%.
The first suggestion that the enzyme might be located in the "periplasmic space" came from experiments in which cultures of E. coli B/RE130 were osmotically shocked, and the medium ("shock fluid") and cell extract prepared from shocked, sonically treated cells were assayed for their ability to inactivate Sm. Morethan 50%of the enzymatic activity (evaluated by bioassay) was released into the shock fluid in experiments with cells in the logarithmic phase. In these experiments, viable counts done on the cell suspensions immediately before and after the resuspension and incubation of the cell pellet in hypotonic solution assured us that more than 70% of the cells survived osmotic shock. Accordingly, ,3-galactosi- explained by assuming the substrate specificity of the enzyme to be broad enough such that it can use both nucleoside triphosphates to adenylate Sm. Precedents for this situation exist among certain ATP-requiring enzymes of glycolytic pathways which phosphorylate their substrates nearly as well with dATP (for example, yeast hexokinase).
With respect to aminoglycoside specificity, the fact that the adenylating enzyme was ineffective against Kana or Neo under the conditions used for Sm inactivation is of interest in light of the work of Umezawa et al. (11, 22) . They reported the existence of Kana-, dihydrostreptomycin-, and paromamine-inactivating activity in the soluble fraction of a single R factor-bearing strain (resistant to these three drugs) but In accord with the findings of Yamada et al. (27) , who determined that the 3' OH group of the N-methyl-L-glucosamine moiety of Sm is adenylated, our results, obtained by different methods, suggest that the streptobiosamine moiety, and not the streptidine ring of the molecule, is adenylated. Recently, Takasawa et al. (21) confirmed that adenylation of Sm occurs at this 3' OH group. Similarly, all of the other presently established sites of R factor-mediated enzymatic alteration of aminoglycoside molecules [Kana acetylation (23) , Kana phosphorylation (11, 23) , and paromamine phosphorylation (22) ] are on either deoxyglucose or N-methyl-L-glucosamine rings and not on the streptose, deoxystreptamine, or streptidine rings of the molecules. If alteration at these sites, particularly as small a change as the addition of a phosphate group, removes the capacity of the drug to inhibit protein synthesis or cause misreading, or both, such enzymes should prove to be useful tools for future studies of the interaction between active sites on the drug molecule and the ribosome.
To our knowledge, before the discovery of the adenylation of Sm (24) , nothing had been reported concerning enzymatic adenylation of either antibiotics or sugars. In fact, reactions involving adenylation of any class of substrate are relatively rare in nature and seem to occur only (i) where the adenylated molecule is an intermediate in a reaction which is subsequently broken down to form the product (e.g., amino acid activation and coenzyme A biosynthesis) or (ii) when activation of enzymes occurs through covalent bonding of AMP (e.g., muscle phosphorylase, glutamine synthetase). Thus, the reaction catalyzed here would appear to be of a highly unusual type, and the "origin" or "evolution" of this episome-coded, Sm-inactivating enzyme remains obscure. 
